Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

258 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Not Yet Recruiting

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

NCT04889742

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +62 more
Locations: Klinik für Radioonkologie und Strahlentherapie Berlin, Germany

View Trial Details

Not Yet Recruiting

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

NCT05967481

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study

NCT04788927

Conditions: Disease Attributes, Disease Susceptibility, Genetic Predisposition to Disease, +15 more
Locations: Rigshospitalet Copenhagen, Denmark

National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark

View Trial Details

Completed

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

NCT06122610

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: University of Wisconsin - Madison Madison, Wisconsin, United States

View Trial Details

Completed

PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation

NCT02134639

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: CHU de Bordeaux Bordeaux, France

View Trial Details

Completed

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

NCT04510311

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

NCT03910660

Conditions: Carcinoma, Carcinoma, Small Cell, Genital Diseases, +17 more
Locations: University of California San Francisco (UCSF) San Francisco, California, United States

BioXcel Clinical Research Site Denver, Colorado, United States

Yale University New Haven, Connecticut, United States

Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

NCT01744249

Conditions: Advanced Cancer, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Marburg Universitätsklinikum Giessen und Marburg GmbH Marburg, Germany

Azienda Ospedaliera Universitaria di Perugia Perugia, Italy

Sapienza, Universitá di Roma, Ospedale sant'Andrea Rome, Italy

Institut Català d'Oncologia L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain

View all 26 locations

View Trial Details

Completed

177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours

NCT04375267

Conditions: Adenoma, Clinical Trial, Phase I, Hemic and Lymphatic Diseases, +15 more
Locations: Dept of Oncology Gothenburg, Sweden

View Trial Details

Completed

Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors

NCT04365023

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Gastroenterology and digestive oncology unit - Cochin hospital Paris, France

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions